Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Search

Search

Close

Trending

Takeda, Daiichi-backed wearable study planned in Japan

Amwell’s SilverCloud buy yields new digital tool for mental health

Dupixent claims new territory in eosinophilic oesophagitis

AbbVie files continuous Parkinson’s therapy ABBV-951 in US

USAID on expanding digital health globally – part two

dry eye

Novartis takes aim at Shire and Allergan with dry-eye drug

News/ Novartis/ UK & Europe

Novartis takes aim at Shire and Allergan with dry-eye drug

Richard Staines Allergan, dry eye, Novartis, ophthalmology, Shire 0 Comment

Swiss company takes option on Lubris’ ECF843.

X

Novartis takes aim at Shire and Allergan with dry-eye drug

https://pharmaphorum.com/news/novartis-takes-aim-shire-allergan-dry-eye-drug/

iStock_74830495_MEDIUM 1

Shire launches potential blockbuster dry eye drug in US

Richard Staines dry eye, ophthalmology, R&D, Shire 0 Comment

Xiidra could be ophthalmology blockbuster.

X

Shire launches potential blockbuster dry eye drug in US

https://pharmaphorum.com/news/shire-launches-dry-eye-drug-us/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Patient Engagement Event - a real world snapshot, beyond the talk

Most popular

Most Viewed

AbbVie files continuous Parkinson's therapy ABBV-951 in US
Dupixent claims new territory in eosinophilic oesophagitis
PTC gets green light for gene therapy Upstaza in EU
CHMP backs Sanofi's Xenpozyme as first drug for ASMD
Amwell's SilverCloud buy yields new digital tool for mental health

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com